Deep Medicine Acquisition - Units (1 Ord Share Class A , 1Right) Profit Margin

Deep Medicine Acquisition - Units (1 Ord Share Class A , 1Right) (DMAQU) currently reports a profit margin of -75.66% as of March 2026. That compares with -45.71% in the prior-year period — down 65.5% year over year. That is below the sector sector average of 19.61%. Use the charts on this page to explore Deep Medicine Acquisition - Units (1 Ord Share Class A , 1Right)'s profit margin history and peer comparisons.

Deep Medicine Acquisition - Units (1 Ord Share Class A , 1Right)'s profit margin decreased from -45.71% to -75.66% — a 65.5% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Deep Medicine Acquisition - Units (1 Ord Share Class A , 1Right)'s profit margin of -75.66% is lower than the its sector sector average of 19.61%. That is roughly 485.9% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Deep Medicine Acquisition - Units (1 Ord Share Class A , 1Right)'s current -75.66% should be judged against industry norms (sector average: 19.61%) and against DMAQU's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -75.66%, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is 19.61%. From there, open related valuation or income-statement pages for Deep Medicine Acquisition - Units (1 Ord Share Class A , 1Right), and consider following DMAQU for alerts when major investors trade the stock.